Radiation concurrent with gemcitabine for locally advanced head and neck cancer: A phase I trial and intracellular drug incorporation study

Journal of Clinical Oncology

Volumn 19, Issue 3, 2001, Pages 792-799

  Eisbruch, A ^a   Shewach, D S ^a   Bradford, C R ^a   Littles, J F ^a   Teknos, T N ^a   Chepeha, D B ^a   Marentette, L J ^a   Terrell, J E ^a   Hogikyan, N D ^a   Dawson, L A ^a   Urba, S ^a   Wolf, G T ^a   Lawrence, T S ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE CALCULATION; DRUG TISSUE LEVEL; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; PHARYNX DISEASE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIOSENSITIZATION; TREATMENT OUTCOME; TUMOR BIOPSY;

EID: 0035253713     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.3.792     Document Type: Article

References (39)

1. Concomitant chemoradio-therapy as primary therapy for locoregionally advanced head and neck cancer
2. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer
3. A randomized clinical trial to compare radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer
4. Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy
5. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
6. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma
7. Hydroxyurea and radiation in head and neck cancer: Results of a randomized study
8. Radiation alone versus radiation with weekly low dose cis-platinum in unresectable cancer of the head and neck
9. Combined bleomycin and radiotherapy in oral cancer
10. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale mitomycin randomized trials
11. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter trial
12. Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine
13. Inhibition of ribonucleotide reduction in CCRF-CEM cells by gemcitabine
14. Phase I studies with the novel nucleoside analog gemcitabine
15. Metabolism of 2′,2′ difluoro-2′-deoxycytidine and radiation sensitization of human colon carcinoma cells
16. Radiosensitization of human solid tumor cell lines with gemcitabine
17. Radiosensitization of pancreatic cells by 2′,2′-difluoro-2′-deoxycytidine
18. Gemcitabine-mediated radiosensitization
19. Effect of 2′,2′-difluorodeoxycytidine on the viability and radiosensitivity of EMT6 cells in vitro
20. A phase I clinical, plasma, and cellular pharmacology study of gemcitabine
21. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
22. Quantitation of deoxyribonucleoside 5′-triphosphate by sequential boronate and anion exchange high-pressure liquid chromatographic procedure
23. Radiotherapy and concomitant weekly paclitaxel in the treatment of head and neck cancer: Results from a phase I trial
24. Gemcitabine, 5-FU and paclitaxel with concomitant radiotherapy in recurrent or advanced head and neck cancer
25. Gemcitabine and radiation therapy for non-small cell lung cancer
26. Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer
27. A phase I study of gemcitabine in combination with radiation therapy in patients with localized, unresectable pancreatic cancer
28. Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: A phase II study of radiotherapy with cisplatin and continuous infusion fluorouracil
29. Concurrent paclitaxel, carboplatin and radiotherapy in advanced head and neck cancer: A phase I study
30. Side effects of chemotherapy: Case 1. Radiation recall dermatitis from gemcitabine
31. Side effects of chemotherapy: Case 2. Radiation recall reaction induced by gemcitabine
32. Schedule dependence of sensitivity to gemcitabine in relation to accumulation and retention of its triphosphate in solid tumor cell lines and solid tumors
33. Modulatory activity of gemcitabine on the phosphorylation and cytotoxicity of arabynosyl nucleotides
34. Antitumor activity of prolonged as compared with bolus administration of gemcitabine in vivo against murine colon tumors
35. Radiosensitization produced by once versus twice daily gemcitabine
36. Enhancement of tumor radioresponse in vivo by gemcitabine
37. Maximizing therapeutic gain with gemcitabine and fractionated radiation